Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 June;57(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 June;57(2):207-15



A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 June;57(2):207-15


Trafficking and homing of systemically administered stem cells: the need for appropriate analysis tools of radionuclide images

Sambuceti G. 1, 2, Massollo M. 1, Marini C. 3, Podestà M. 4, Cassanelli C. 4, Morbelli S. 1, Fiz F. 1, Buschiazzo A. 1, Capitanio S. 1, Augeri C. 1, Curti G. 1, Piana M. 5, Frassoni F. 2

1 Nuclear Medicine, Department of Internal Medicine University of Genoa, Genoa, Italy;
2 Center for Avanced Biotechnology, Genoa, Italy;
3 CNR Institute of Bioimages and Molecular Physiology Section of Genoa, Genoa, Italy;
4 Stem Cell Center, University Hospital San Martino Genoa, Italy;
5 Department of Mathematics University of Genoa, Genoa, Italy

Aim: Despite its enormous relevance, homing of hematopoietic stem cells (SCs) remains relatively uncertain due to the limitations of measuring small number of systemically administered cells in the different organs. Despite its high sensitivity, radionuclide detection has been relatively underutilized to this purpose since it cannot differentiate hematopietic SCs recruited by target tissues from those circulating in the blood pool. Our study aims to verify the potential of tracer kinetic approaches in estimating the recruitment of labeled SCs after their systemic administration.
Methods: Twenty-four Lewis rats underwent administration of 2 millions cells labeled with 37 MBq of 99mTc-exametazime. Animals were divided into 2 groups according to administered cells: hematopoietic SCs or cells obtained from a line of rat hepatoma. Cell injection was performed during a planar dynamic acquisition. Regions of interest were positioned to plot time activity curves on heart, lungs, liver and spleen. Blood cell clearance was evaluated according to common stochastic analysis approach. Either fraction of dose in each organ at the end of the experiment or computing the slope of regression line provided by Patlak or Logan graphical approach estimated cell recruitment. At the end of the study, animals were sacrificed and the number of cells retained in the same organs was estimated by in vitro counting.
Results: Cell number, documented by the dose fraction retained in each organ at imaging was consistently higher with respect to the “gold standard” in vitro counting in all experiments. An inverse correlation was observed between degree of overestimation and blood clearance of labeled cells (r=-0.56, P<0.05). Logan plot analysis consistently provided identifiable lines, whose slope values closely agreed with the “in vitro” estimation of hepatic and splenic cell recruitment.
Conclusion: The simple evaluation of organ radioactivity concentration does not provide reliable estimates of local recruitment of systemically administered cells. Yet, the combined analysis of temporal trends of tracer (cell) tissue accumulation and blood clearance can provide quantitative estimations of cell homing in the different organs.

language: English


top of page